WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017060923) FREEZE DRIED PARENTERAL FORMULATION OF MICAFUNGIN SODIUM AND TO PROCESS THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/060923    International Application No.:    PCT/IN2016/050341
Publication Date: 13.04.2017 International Filing Date: 07.10.2016
IPC:
A61K 31/00 (2006.01)
Applicants: GUFIC BIOSCIENCES LIMITED [IN/IN]; N.H.No.8, Near Grid, Kabilpore Navsari, Gujarat 396424 (IN)
Inventors: PATEL, Mitesh Natavarlal; (IN).
DAVE, Mafatlal Tribhovandas; (IN).
CHOKSI, Pranavkumar Jayesh; (IN)
Agent: NAIR, Gopakumar G.; (IN)
Priority Data:
3858/MUM/2015 10.10.2015 IN
Title (EN) FREEZE DRIED PARENTERAL FORMULATION OF MICAFUNGIN SODIUM AND TO PROCESS THEREOF
(FR) FORMULATION PARENTÉRALE LYOPHILISÉE DE MICAFUNGINE SODIQUE ET SON PROCÉDÉ
Abstract: front page image
(EN)The present invention discloses stable freeze dried pharmaceutical formulations of Micafungin which comprises Micafungin sodium; a suitable stabilizing agent and alkalizing agent, for parenteral administration, wherein, the formulation is devoid of polysaccharide, disaccharide or mammalian derived stabilizing agent Lactose. The pharmaceutical formulation provides sufficient stabilization of Micafungin sodium thus improving the shelf life of the product during storage.
(FR)La présente invention concerne des formulations pharmaceutiques lyophilisées stables de micafungine qui comprend de la micafungine sodique ; un agent stabilisant et un agent alcalifiant appropriés pour une administration parentérale, la formulation étant dépourvue d'agent de stabilisation lactose dérivé de polysaccharide, de disaccharide ou de mammifère. La formulation pharmaceutique permet d'obtenir une stabilisation suffisante de la micafungine sodique, améliorant ainsi la durée de conservation du produit au cours du stockage.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)